Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alphatec Holdings, the parent company of Alphatec Spine, a medical technology company, has launched its new ProFUSE demineralized bone scaffold, expanding the company's orthobiologics product line.
Subscribe to our email newsletter
The ProFUSE demineralized bone scaffold is a porous, malleable allograft that can be used with Alphatec Spine’s Novel spacers and AlphaGRAFT structural allografts.
The ProFUSE product provides a natural scaffold derived entirely of bone that can be placed into a void within a spacer or on top of a spacer. The sponge-like qualities of the ProFUSE scaffold allows a surgeon to compress the ProFUSE and place it into a small space, the company said.
Following placement, the ProFUSE scaffold will expand to foster maximum contact between the spacer and the endplate of the vertebral body and is designed to promote fusion. The ProFUSE product comes pre-packaged in Alphatec Spine’s new and proprietary vacuum infusion packaging (VIP) system.
In addition, Alphatec Spine expects to launch AlphaGRAFT structural allograft spacers packaged in the VIP to the market in early 2009.
Dirk Kuyper, president and CEO of Alphatec Spine, said: “Our ProFUSE demineralized bone scaffold and VIP packaging, directly supports our strategy of expanding our product portfolio with innovative orthobiologics solutions. This launch compliments Alphatec Spine’s product offering and affords a significant opportunity to participate in the $1.7 billion US orthobiologics market.”